Primary Site >> Pancreatic Cancer

Gene >> SRC

Journal: Biochem Biophys Res Commun. 1998 Feb 13;243(2):503-8.
Title: Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma.
Author: Lutz, M P|Esser, I B|Flossmann-Kast, B B|Vogelmann, R|Luhrs, H|Friess, H|Buchler, M W|Adler, G
PMID: 9480838
Journal: Cancer Res. 1998 Aug 15;58(16):3551-4.
Title: Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cells.
Author: Flossmann-Kast, B B|Jehle, P M|Hoeflich, A|Adler, G|Lutz, M P
PMID: 9721859
Journal: Cancer Res. 2001 Jan 15;61(2):589-93.
Title: AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells.
Author: Tanno, S|Tanno, S|Mitsuuchi, Y|Altomare, D A|Xiao, G H|Testa, J R
PMID: 11212254
Journal: Ann Oncol. 2001;12 Suppl 2:S13-7.
Title: Oncogenes, growth factors, receptor expression and proliferation markers in digestive neuroendocrine tumours. A critical reappraisal.
Author: Delle Fave, G|Corleto, V D
PMID: 11762339
Journal: Biochem Biophys Res Commun. 2003 Feb 28;302(1):46-55.
Title: Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line.
Author: Zeng, Huiyan|Datta, Kaustubh|Neid, Matthias|Li, Jinping|Parangi, Sareh|Mukhopadhyay, Debabrata
PMID: 12593846
Journal: Cancer Res. 2003 May 15;63(10):2379-87.
Title: Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Author: Guha, Sushovan|Lunn, J Adrian|Santiskulvong, Chintda|Rozengurt, Enrique
PMID: 12750255
Journal: J Biol Chem. 2003 Sep 26;278(39):38029-39. Epub 2003 Jun 27.
Title: Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin.
Author: Wen, Yunfei|Caffrey, Thomas C|Wheelock, Margaret J|Johnson, Keith R|Hollingsworth, Michael A
PMID: 12832415
Journal: Cancer Metastasis Rev. 2003 Dec;22(4):337-58.
Title: Src family kinases in tumor progression and metastasis.
Author: Summy, Justin M|Gallick, Gary E
PMID: 12884910
Journal: Surgery. 2003 Aug;134(2):221-6.
Title: Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness.
Author: Ito, Hiromichi|Gardner-Thorpe, James|Zinner, Michael J|Ashley, Stanley W|Whang, Edward E
PMID: 12947321
Journal: Dig Dis Sci. 2003 Oct;48(10):1972-8.
Title: Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma.
Author: Hakam, Ardeshir|Fang, Quan|Karl, Richard|Coppola, Domenico
PMID: 14627343
Journal: Int J Mol Med. 2004 Mar;13(3):473-8.
Title: Identification and characterization of human DIAPH3 gene in silico.
Author: Katoh, Masuko|Katoh, Masaru
PMID: 14767582
Journal: J Biol Chem. 2004 Sep 24;279(39):40400-4. Epub 2004 Jul 29.
Title: Agonist-independent activation of Src tyrosine kinase by a cholecystokinin-2 (CCK2) receptor splice variant.
Author: Olszewska-Pazdrak, Barbara|Townsend, Courtney M Jr|Hellmich, Mark R
PMID: 15292208
Journal: Clin Cancer Res. 2004 Dec 1;10(23):8028-36.
Title: Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice.
Author: Yezhelyev, Maksim V|Koehl, Gudrun|Guba, Markus|Brabletz, Thomas|Jauch, Karl-Walter|Ryan, Anderson|Barge, Alan|Green, Tim|Fennell, Michael|Bruns, Christiane J
PMID: 15585638
Journal: Cancer Res. 2005 Aug 15;65(16):7214-22.
Title: Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis.
Author: Trevino, Jose G|Summy, Justin M|Gray, Michael J|Nilsson, Monique B|Lesslie, Donald P|Baker, Cheryl H|Gallick, Gary E
PMID: 16103072
Journal: Pancreas. 2005 Oct;31(3):263-74.
Title: c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK.
Author: Summy, Justin M|Trevino, Jose G|Baker, Cheryl H|Gallick, Gary E
PMID: 16163059
Journal: Mol Cancer Ther. 2005 Dec;4(12):1900-11.
Title: AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes.
Author: Summy, Justin M|Trevino, Jose G|Lesslie, Donald P|Baker, Cheryl H|Shakespeare, William C|Wang, Yihan|Sundaramoorthi, Raji|Metcalf, Chester A 3rd|Keats, Jeffrey A|Sawyer, Tomi K|Gallick, Gary E
PMID: 16373705
Journal: J Biol Chem. 2006 Feb 24;281(8):4570-9.
Title: Epithelial growth factor-induced phosphorylation of caveolin 1 at tyrosine 14 stimulates caveolae formation in epithelial cells.
Author: Orlichenko, Lidiya|Huang, Bing|Krueger, Eugene|McNiven, Mark A
PMID: 16332692
Journal: Am J Pathol. 2006 Mar;168(3):962-72.
Title: Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.
Author: Trevino, Jose G|Summy, Justin M|Lesslie, Donald P|Parikh, Nila U|Hong, David S|Lee, Francis Y|Donato, Nicholas J|Abbruzzese, James L|Baker, Cheryl H|Gallick, Gary E
PMID: 16507911
Journal: Mol Cancer Ther. 2006 Mar;5(3):621-9.
Title: Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein.
Author: Kotha, Anupama|Sekharam, Madhavi|Cilenti, Lucia|Siddiquee, Khandaker|Khaled, Annette|Zervos, Antonis S|Carter, Bradford|Turkson, James|Jove, Richard
PMID: 16546976
Journal: Drug Resist Updat. 2006 Feb-Apr;9(1-2):1-18. Epub 2006 Apr 18.
Title: Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?
Author: Kleespies, Axel|Jauch, Karl-Walter|Bruns, Christiane J
PMID: 16621676
Journal: Int J Oncol. 2006 Jul;29(1):125-38.
Title: Inhibition of PDGFR phosphorylation and Src and Akt activity by GN963 leads to therapy of human pancreatic cancer growing orthotopically in nude mice.
Author: Baker, Cheryl H|Trevino, Jose G|Summy, Justin M|Zhang, Fahao|Caron, Alexis|Nesbit, Mark|Gallick, Gary E|Fidler, Isaiah J
PMID: 16773192
Journal: Angiogenesis. 2006;9(2):101-10. Epub 2006 Jul 27.
Title: Src activation of Stat3 is an independent requirement from NF-kappaB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells.
Author: Trevino, Jose G|Gray, Michael J|Nawrocki, Steffan T|Summy, Justin M|Lesslie, Donald P|Evans, Douglas B|Sawyer, Tomi K|Shakespeare, William C|Watowich, Stephanie S|Chiao, Paul J|McConkey, David J|Gallick, Gary E
PMID: 16871430
Journal: World J Gastroenterol. 2006 Jul 28;12(28):4498-503.
Title: Mechanism for Src activation by the CCK2 receptor: Patho-physiological functions of this receptor in pancreas.
Author: Ferrand, Audrey|Vatinel, Sebastien|Kowalski-Chauvel, Aline|Bertrand, Claudine|Escrieut, Chantal|Fourmy, Daniel|Dufresne, Marlene|Seva, Catherine
PMID: 16874861
Journal: J Med Chem. 2006 Nov 2;49(22):6465-88.
Title: N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor.
Author: Hennequin, Laurent F|Allen, Jack|Breed, Jason|Curwen, Jon|Fennell, Michael|Green, Tim P|Lambert-van der Brempt, Christine|Morgentin, Remy|Norman, Richard A|Olivier, Annie|Otterbein, Ludovic|Ple, Patrick A|Warin, Nicolas|Costello, Gerard
PMID: 17064066
Journal: Int J Gastrointest Cancer. 2006;37(4):110-9.
Title: Characterization of the CXCR4 signaling in pancreatic cancer cells.
Author: Billadeau, Daniel D|Chatterjee, Subrha|Bramati, Patricia|Sreekumar, Raghavakaimal|Shah, Vijay|Hedin, Karen|Urrutia, Raul
PMID: 18175225
Journal: Cancer Lett. 2007 Jan 8;245(1-2):242-51. Epub 2006 Mar 15.
Title: Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
Author: Hirokawa, Yumiko|Levitzki, Alexander|Lessene, Guillaume|Baell, Jonathan|Xiao, Yi|Zhu, Hongjian|Maruta, Hiroshi
PMID: 16540233
Journal: Oncogene. 2007 Oct 18;26(48):6851-62. Epub 2007 Apr 30.
Title: Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1.
Author: Cordes, N|Frick, S|Brunner, T B|Pilarsky, C|Grutzmann, R|Sipos, B|Kloppel, G|McKenna, W G|Bernhard, E J
PMID: 17471232
Journal: Angiogenesis. 2007;10(3):167-82.
Title: Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.
Author: Ischenko, Ivan|Guba, Markus|Yezhelyev, Maksim|Papyan, Armine|Schmid, Gerald|Green, Tim|Fennell, Michael|Jauch, Karl-Walter|Bruns, Christiane J
PMID: 17486419
Journal: Cancer Res. 2007 Nov 1;67(21):10309-16.
Title: Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
Author: Matsushita, Arikira|Gotze, Tobias|Korc, Murray
PMID: 17974973
Journal: Anticancer Agents Med Chem. 2007 Nov;7(6):651-9.
Title: SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy.
Author: Johnson, Faye M|Gallick, Gary E
PMID: 18045060
Journal: Cancer Lett. 2008 Feb 18;260(1-2):155-62. Epub 2007 Dec 19.
Title: Inhibition of Src reduces gemcitabine-induced cytotoxicity in human pancreatic cancer cell lines.
Author: Ichihara, Naoto|Kubota, Yoshitsugu|Kitanaka, Akira|Tanaka, Terukazu|Taminato, Tomohiko
PMID: 18078709
Journal: Recent Results Cancer Res. 2008;177:179-85.
Title: Src kinase and pancreatic cancer.
Author: Hilbig, A
PMID: 18084959
Journal: Curr Med Chem. 2008;15(10):978-90.
Title: ANTI-ADHESION evolves to a promising therapeutic concept in oncology.
Author: Schmidmaier, R|Baumann, P
PMID: 18393855
Journal: Oncogene. 2008 Dec 4;27(57):7212-22.
Title: Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.
Author: Ischenko, I|Camaj, P|Seeliger, H|Kleespies, A|Guba, M|De Toni, E N|Schwarz, B|Graeb, C|Eichhorn, M E|Jauch, K-W|Bruns, C J
PMID: 18794807
Journal: Br J Cancer. 2008 Oct 7;99(7):1074-82.
Title: Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer.
Author: Chang, Q|Jorgensen, C|Pawson, T|Hedley, D W
PMID: 18797457
Journal: Expert Rev Gastroenterol Hepatol. 2008 Oct;2(5):673-96.
Title: New treatment options for advanced pancreatic cancer.
Author: Middleton, Gary|Ghaneh, Paula|Costello, Eithne|Greenhalf, William|Neoptolemos, John P
PMID: 19072345
Journal: Biologics. 2008 Dec;2(4):707-15.
Title: Small molecule tyrosine kinase inhibitors in pancreatic cancer.
Author: Gupta, Sachin|El-Rayes, Bassel F
PMID: 19707451
Journal: Int J Cancer. 2009 Jan 15;124(2):280-6.
Title: Activation of Src and Src-associated signaling pathways in relation to hypoxia in human cancer xenograft models.
Author: Pham, Nhu-An|Magalhaes, Joao M M M|Do, Trevor|Schwock, Joerg|Dhani, Neesha|Cao, Ping-Jiang|Hill, Richard P|Hedley, David W
PMID: 18924149
Journal: Biochem Biophys Res Commun. 2009 Feb 6;379(2):445-50.
Title: EGF promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and activation of MMP-2.
Author: Binker, Marcelo G|Binker-Cosen, Andres A|Richards, Daniel|Oliver, Brenda|Cosen-Binker, Laura I
PMID: 19116140
Journal: Cancer Res. 2009 Feb 15;69(4):1383-91.
Title: Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis.
Author: Ricono, Jill M|Huang, Miller|Barnes, Leo A|Lau, Steven K|Weis, Sara M|Schlaepfer, David D|Hanks, Steven K|Cheresh, David A
PMID: 19208836
Journal: Cancer Sci. 2009 Apr;100(4):770-7.
Title: Phosphoinositide 3-kinase inhibitor (wortmannin) inhibits pancreatic cancer cell motility and migration induced by hyaluronan in vitro and peritoneal metastasis in vivo.
Author: Teranishi, Futoshi|Takahashi, Naoko|Gao, Nan|Akamo, Yoshimi|Takeyama, Hiromitsu|Manabe, Tadao|Okamoto, Takashi
PMID: 19469020
Journal: Clin Cancer Res. 2009 Jun 15;15(12):4138-46.
Title: Antitumor effects and biomarkers of activity of AZD0530, a Src inhibitor, in pancreatic cancer.
Author: Rajeshkumar, N V|Tan, Aik Choon|De Oliveira, Elizabeth|Womack, Chris|Wombwell, Helen|Morgan, Shethah|Warren, Madhuri V|Walker, Jill|Green, Tim P|Jimeno, Antonio|Messersmith, Wells A|Hidalgo, Manuel
PMID: 19509160
Journal: Mol Cancer Ther. 2009 Jun;8(6):1484-93.
Title: Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts.
Author: Messersmith, Wells A|Rajeshkumar, N V|Tan, Aik Choon|Wang, Xiao Fei|Diesl, Veronica|Choe, Sung E|Follettie, Max|Coughlin, Christina|Boschelli, Frank|Garcia-Garcia, Elena|Lopez-Rios, Fernando|Jimeno, Antonio|Hidalgo, Manuel
PMID: 19509264
Journal: Nat Med. 2009 Oct;15(10):1163-9.
Title: An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression.
Author: Desgrosellier, Jay S|Barnes, Leo A|Shields, David J|Huang, Miller|Lau, Steven K|Prevost, Nicolas|Tarin, David|Shattil, Sanford J|Cheresh, David A
PMID: 19734908
Journal: Biochem Pharmacol. 2010 May 15;79(10):1398-409.
Title: A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes.
Author: Zhang, Xiaolei|Yue, Peibin|Fletcher, Steven|Zhao, Wei|Gunning, Patrick T|Turkson, James
PMID: 20067773
Journal: J Pharmacol Exp Ther. 2010 May;333(2):373-81.
Title: Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant signal transducer and activator of transcription 3 and epidermal growth factor receptor or Src.
Author: Jaganathan, Soumya|Yue, Peibin|Turkson, James
PMID: 20100905
Journal: JOP. 2010 Mar 5;11(2):151-3.
Title: Any second-line therapy for advanced pancreatic cancer? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Author: Li, Jia|Merl, Man Yee|Saif, Muhammad Wasif
PMID: 20208325
Journal: PLoS One. 2010 Mar 4;5(3):e9430.
Title: Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model.
Author: Humbert, Martine|Casteran, Nathalie|Letard, Sebastien|Hanssens, Katia|Iovanna, Juan|Finetti, Pascal|Bertucci, Francois|Bader, Thomas|Mansfield, Colin D|Moussy, Alain|Hermine, Olivier|Dubreuil, Patrice
PMID: 20209107
Journal: Curr Cancer Drug Targets. 2010 Aug;10(5):546-53.
Title: Src tyrosine kinase inhibition suppresses lymphangiogenesis in vitro and in vivo.
Author: Ischenko, I|Seeliger, H|Camaj, P|Kleespies, A|Guba, M|Eichhorn, M E|Jauch, K-W|Bruns, C J
PMID: 20370688
Journal: J Biol Chem. 2010 Jul 23;285(30):23075-85.
Title: Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.
Author: Lazer, Galit|Pe'er, Liron|Farago, Marganit|Machida, Kazuya|Mayer, Bruce J|Katzav, Shulamit
PMID: 20457609
Journal: Ann Surg Oncol. 2010 Oct;17(10):2619-27.
Title: Higher expression of the heterogeneous nuclear ribonucleoprotein k in melanoma.
Author: Wen, Fushi|Shen, Alex|Shanas, Renee|Bhattacharyya, Achyut|Lian, Fangru|Hostetter, Galen|Shi, Jiaqi
PMID: 20499280
Journal: Mol Cancer Ther. 2010 Aug;9(8):2322-32.
Title: Targeted inhibition of SRC kinase signaling attenuates pancreatic tumorigenesis.
Author: Nagaraj, Nagathihalli S|Smith, J Joshua|Revetta, Frank|Washington, M Kay|Merchant, Nipun B
PMID: 20682659
Journal: Mol Carcinog. 2010 Dec;49(12):1007-21.
Title: Loss of tyrosine phosphatase-dependent inhibition promotes activation of tyrosine kinase c-Src in detached pancreatic cells.
Author: Connelly, Sarah F|Isley, Beth A|Baker, Cheryl H|Gallick, Gary E|Summy, Justin M
PMID: 20945416
Journal: Front Biosci (Elite Ed). 2011 Jan 1;3:750-6.
Title: Focal adhesion kinase signaling and function in pancreatic cancer.
Author: Ucar, Deniz A|Dang, Long H|Hochwald, Steven N
PMID: 21196348
Journal: Oncogene. 2011 May 5;30(18):2123-34.
Title: Oncogenic Ras/Src cooperativity in pancreatic neoplasia.
Author: Shields, D J|Murphy, E A|Desgrosellier, J S|Mielgo, A|Lau, S K M|Barnes, L A|Lesperance, J|Huang, M|Schmedt, C|Tarin, D|Lowy, A M|Cheresh, D A
PMID: 21242978
Journal: Clin Cancer Res. 2011 Feb 1;17(3):483-93.
Title: Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth.
Author: Nagaraj, Nagathihalli S|Washington, M Kay|Merchant, Nipun B
PMID: 21266529
Journal: Transl Oncol. 2011 Apr 1;4(2):83-91.
Title: Identification and validation of SRC and phospho-SRC family proteins in circulating mononuclear cells as novel biomarkers for pancreatic cancer.
Author: Yokoi, Kenji|Hawke, David|Oborn, Carol J|Jang, Jin-Young|Nishioka, Yasuhiko|Fan, Dominic|Kim, Seung Wook|Kim, Sun-Jin|Fidler, Isaiah J
PMID: 21461171
Journal: PLoS One. 2011 May 5;6(5):e19605.
Title: A functional nuclear epidermal growth factor receptor, SRC and Stat3 heteromeric complex in pancreatic cancer cells.
Author: Jaganathan, Soumya|Yue, Peibin|Paladino, David C|Bogdanovic, Jelena|Huo, Qun|Turkson, James
PMID: 21573184
Journal: J Biol Chem. 2011 Jul 15;286(28):24776-84.
Title: Calmodulin mediates Fas-induced FADD-independent survival signaling in pancreatic cancer cells via activation of Src-extracellular signal-regulated kinase (ERK).
Author: Yuan, Kaiyu|Jing, Gu|Chen, Jianfeng|Liu, Hui|Zhang, Kui|Li, Yuebin|Wu, Hui|McDonald, Jay M|Chen, Yabing
PMID: 21613217
Journal: Mol Cancer Ther. 2011 Nov;10(11):2083-93.
Title: Digitoxin-induced cytotoxicity in cancer cells is mediated through distinct kinase and interferon signaling networks.
Author: Prassas, Ioannis|Karagiannis, George S|Batruch, Ihor|Dimitromanolakis, Apostolos|Datti, Alessandro|Diamandis, Eleftherios P
PMID: 21859838
Journal: Oncology. 2011;81(3-4):259-72.
Title: Molecular pathogenesis of pancreatic cancer and clinical perspectives.
Author: Matthaios, D|Zarogoulidis, P|Balgouranidou, I|Chatzaki, E|Kakolyris, S
PMID: 22116519
Journal: Invest New Drugs. 2012 Apr;30(2):779-86.
Title: A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer.
Author: Renouf, Daniel J|Moore, Malcolm J|Hedley, David|Gill, Sharlene|Jonker, Derek|Chen, Eric|Walde, David|Goel, Rakesh|Southwood, Bernadette|Gauthier, Isabelle|Walsh, Wendy|McIntosh, Lynn|Seymour, Lesley
PMID: 21170669
Journal: Oncogene. 2012 Mar 8;31(10):1228-41.
Title: Increased expression of the large GTPase dynamin 2 potentiates metastatic migration and invasion of pancreatic ductal carcinoma.
Author: Eppinga, R D|Krueger, E W|Weller, S G|Zhang, L|Cao, H|McNiven, M A
PMID: 21841817
Journal: Oncogene. 2012 May 31;31(22):2783-93.
Title: EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation.
Author: Huang, M|Anand, S|Murphy, E A|Desgrosellier, J S|Stupack, D G|Shattil, S J|Schlaepfer, D D|Cheresh, D A
PMID: 21963850
Journal: Mol Cell Biochem. 2012 Mar;362(1-2):65-70.
Title: The non-receptor tyrosine kinase c-Src mediates the PDGF-induced association between Furin and pro-MT1-MMP in HPAC pancreatic cells.
Author: Shi, Chong|Ma, Yongchao|Liu, Hao|Zhang, Yuxiang|Wang, Zesheng|Jia, Hongti
PMID: 22038627
Journal: Carcinogenesis. 2012 Jan;33(1):191-6.
Title: Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention.
Author: Schuller, Hildegard M|Al-Wadei, Hussein A N|Ullah, Mohammad F|Plummer, Howard K 3rd
PMID: 22072614
Journal: Mol Cancer Res. 2012 Feb;10(2):239-49.
Title: Pancreatic cancer cells and normal pancreatic duct epithelial cells express an autocrine catecholamine loop that is activated by nicotinic acetylcholine receptors alpha3, alpha5, and alpha7.
Author: Al-Wadei, Mohammed H|Al-Wadei, Hussein A N|Schuller, Hildegard M
PMID: 22188668
Journal: Oncol Rep. 2012 Mar;27(3):628-36.
Title: A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Author: Zhao, Xin|Li, De-Chun|Zhao, Hua|Li, Zhi|Wang, Jian-Xin|Zhu, Dong-Ming|Zhou, Jin|Cen, Jian-Nong
PMID: 22200682
Journal: Carcinogenesis. 2012 Mar;33(3):555-62.
Title: DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
Author: He, Xiangyi|Zheng, Zhong|Li, Jianfang|Ben, Qiwen|Liu, Jun|Zhang, Jianian|Ji, Jun|Yu, Beiqin|Chen, Xuehua|Su, Liping|Zhou, Lin|Liu, Bingya|Yuan, Yaozong
PMID: 22223849
Journal: Mol Cancer. 2012 Apr 3;11:19.
Title: Syndecan-2 promotes perineural invasion and cooperates with K-ras to induce an invasive pancreatic cancer cell phenotype.
Author: De Oliveira, Tiago|Abiatari, Ivane|Raulefs, Susanne|Sauliunaite, Danguole|Erkan, Mert|Kong, Bo|Friess, Helmut|Michalski, Christoph W|Kleeff, Jorg
PMID: 22471946
Journal: PLoS One. 2012;7(3):e33414.
Title: The tyrosine kinase c-Src directly mediates growth factor-induced Notch-1 and Furin interaction and Notch-1 activation in pancreatic cancer cells.
Author: Ma, Yong-Chao|Shi, Chong|Zhang, Yao-Nan|Wang, Lan-Ge|Liu, Hao|Jia, Hong-Ti|Zhang, Yu-Xiang|Sarkar, Fazlul H|Wang, Ze-Sheng
PMID: 22479394
Journal: Mol Cancer. 2012 Apr 26;11:24.
Title: Nicotine, IFN-gamma and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades.
Author: Kunigal, Sateesh|Ponnusamy, Moorthy P|Momi, Navneet|Batra, Surinder K|Chellappan, Srikumar P
PMID: 22537161
Journal: Cancer Res. 2012 May 15;72(10):2554-64.
Title: KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer.
Author: Kelber, Jonathan A|Reno, Theresa|Kaushal, Sharmeela|Metildi, Cristina|Wright, Tracy|Stoletov, Konstantin|Weems, Jessica M|Park, Frederick D|Mose, Evangeline|Wang, Yingchun|Hoffman, Robert M|Lowy, Andrew M|Bouvet, Michael|Klemke, Richard L
PMID: 22589274
Journal: Front Biosci (Landmark Ed). 2012 Jun 1;17:2059-69.
Title: Src-mediated regulation of E-cadherin and EMT in pancreatic cancer.
Author: Nagathihalli, Nagaraj S|Merchant, Nipun B
PMID: 22652764
Journal: Cell Mol Life Sci. 2012 Nov;69(22):3863-79.
Title: CD24 controls Src/STAT3 activity in human tumors.
Author: Bretz, Niko P|Salnikov, Alexei V|Perne, Claudia|Keller, Sascha|Wang, Xiaoli|Mierke, Claudia T|Fogel, Mina|Erbe-Hofmann, Natalie|Schlange, Thomas|Moldenhauer, Gerhard|Altevogt, Peter
PMID: 22760497
Journal: PLoS One. 2012;7(6):e39684.
Title: Concomitant targeting of EGF receptor, TGF-beta and SRC points to a novel therapeutic approach in pancreatic cancer.
Author: Deharvengt, Sophie|Marmarelis, Melina|Korc, Murray
PMID: 22761868
Journal: Carcinogenesis. 2012 Sep;33(9):1745-53.
Title: Effects of chronic nicotine on the autocrine regulation of pancreatic cancer cells and pancreatic duct epithelial cells by stimulatory and inhibitory neurotransmitters.
Author: Al-Wadei, Mohammed H|Al-Wadei, Hussein A N|Schuller, Hildegard M
PMID: 22791813
Journal: PLoS One. 2012;7(8):e43376.
Title: Celecoxib and GABA cooperatively prevent the progression of pancreatic cancer in vitro and in xenograft models of stress-free and stress-exposed mice.
Author: Al-Wadei, Hussein A N|Al-Wadei, Mohammed H|Ullah, Mohammad F|Schuller, Hildegard M
PMID: 22916251
Journal: Cancer Genet. 2012 Nov;205(11):552-62.
Title: Ror2-Src signaling in metastasis of mouse melanoma cells is inhibited by NRAGE.
Author: Lai, Shan-Shan|Xue, Bin|Yang, Yang|Zhao, Li|Chu, Chao-Shun|Hao, Jia-Yin|Wen, Chuan-Jun
PMID: 23142633
Journal: Neoplasia. 2012 Dec;14(12):1102-14.
Title: Nicotine induces inhibitor of differentiation-1 in a Src-dependent pathway promoting metastasis and chemoresistance in pancreatic adenocarcinoma.
Author: Trevino, Jose G|Pillai, Smitha|Kunigal, Sateesh|Singh, Sandeep|Fulp, William J|Centeno, Barbara A|Chellappan, Srikumar P
PMID: 23308043
Journal: Cancer Med. 2012 Oct;1(2):207-17.
Title: Biomarker-driven trial in metastatic pancreas cancer: feasibility in a multicenter study of saracatinib, an oral Src inhibitor, in previously treated pancreatic cancer.
Author: Arcaroli, John|Quackenbush, Kevin|Dasari, Arvind|Powell, Rebecca|McManus, Martine|Tan, Aik-Choon|Foster, Nathan R|Picus, Joel|Wright, John|Nallapareddy, Sujatha|Erlichman, Charles|Hidalgo, Manuel|Messersmith, Wells A
PMID: 23342270
Journal: Eur J Cancer. 2013 Mar;49(5):1152-8.
Title: Chronic nicotine inhibits the therapeutic effects of gemcitabine on pancreatic cancer in vitro and in mouse xenografts.
Author: Banerjee, Jheelam|Al-Wadei, Hussein A N|Schuller, Hildegard M
PMID: 23146955
Journal: Mol Oncol. 2013 Jun;7(3):369-78.
Title: Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells.
Author: Nam, Sangkil|Wen, Wei|Schroeder, Anne|Herrmann, Andreas|Yu, Hua|Cheng, Xinlai|Merz, Karl-Heinz|Eisenbrand, Gerhard|Li, Hongzhi|Yuan, Yate-Ching|Jove, Richard
PMID: 23206899
Journal: Carcinogenesis. 2013 Mar;34(3):694-702.
Title: Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells.
Author: Park, Eun Hye|Kim, Seokho|Jo, Ji Yoon|Kim, Su Jin|Hwang, Yeonsil|Kim, Jin-Man|Song, Si Young|Lee, Dong-Ki|Koh, Sang Seok
PMID: 23222813
Journal: Pancreas. 2013 Jul;42(5):795-806.
Title: Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.
Author: Gomes, Evan G|Connelly, Sarah F|Summy, Justin M
PMID: 23271399
Journal: Invest New Drugs. 2013 Aug;31(4):967-73.
Title: A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies.
Author: Naing, Aung|Cohen, Roger|Dy, Grace K|Hong, David S|Dyster, Lyn|Hangauer, David G|Kwan, Rudolf|Fetterly, Gerald|Kurzrock, Razelle|Adjei, Alex A
PMID: 23361621
Journal: PLoS One. 2013 May 1;8(5):e61532.
Title: Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice.
Author: Mackenzie, Gerardo G|Huang, Liqun|Alston, Ninche|Ouyang, Nengtai|Vrankova, Kvetoslava|Mattheolabakis, George|Constantinides, Panayiotis P|Rigas, Basil
PMID: 23650499
Journal: Cancer Res. 2013 Aug 1;73(15):4674-86.
Title: Intravital FLIM-FRET imaging reveals dasatinib-induced spatial control of src in pancreatic cancer.
Author: Nobis, Max|McGhee, Ewan J|Morton, Jennifer P|Schwarz, Juliane P|Karim, Saadia A|Quinn, Jean|Edward, Mike|Campbell, Andrew D|McGarry, Lynn C|Evans, T R Jeffry|Brunton, Valerie G|Frame, Margaret C|Carragher, Neil O|Wang, Yingxiao|Sansom, Owen J|Timpson, Pau
PMID: 23749641
Journal: J Thromb Haemost. 2013 Oct;11(10):1892-902.
Title: Protease-activated receptor-2 induces migration of pancreatic cancer cells in an extracellular ATP-dependent manner.
Author: Shi, K|Queiroz, K C S|Stap, J|Richel, D J|Spek, C A
PMID: 23899344
Journal: Cancer Lett. 2013 Dec 1;341(2):166-77.
Title: Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.
Author: Macha, Muzafar A|Rachagani, Satyanarayana|Gupta, Suprit|Pai, Priya|Ponnusamy, Moorthy P|Batra, Surinder K|Jain, Maneesh
PMID: 23920124
Journal: PLoS One. 2013 Dec 5;8(12):e79654.
Title: Quantitative proteomic profiling identifies DPYSL3 as pancreatic ductal adenocarcinoma-associated molecule that regulates cell adhesion and migration by stabilization of focal adhesion complex.
Author: Kawahara, Takeo|Hotta, Naoe|Ozawa, Yukiko|Kato, Seiichi|Kano, Keiko|Yokoyama, Yukihiro|Nagino, Masato|Takahashi, Takashi|Yanagisawa, Kiyoshi
PMID: 24339867
Journal: Curr Biol. 2014 Jan 6;24(1):86-93.
Title: Vav1 as a central regulator of invadopodia assembly.
Author: Razidlo, Gina L|Schroeder, Barbara|Chen, Jing|Billadeau, Daniel D|McNiven, Mark A
PMID: 24332539
Journal: J Clin Invest. 2014 Jan;124(1):338-52.
Title: Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-beta to promote proliferation.
Author: Gore, A Jesse|Deitz, Samantha L|Palam, Lakshmi Reddy|Craven, Kelly E|Korc, Murray
PMID: 24334458
Journal: Oncologist. 2014 Feb;19(2):211.
Title: Src inhibition is still a relevant target in pancreatic cancer.
Author: George, Thomas J Jr|Trevino, Jose G|Liu, Chen
PMID: 24457377
Journal: Mol Cancer. 2014 Jan 27;13:15.
Title: CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis.
Author: Ding, Qiang|Miyazaki, Yumi|Tsukasa, Koichiro|Matsubara, Shyuichiro|Yoshimitsu, Makoto|Takao, Sonshin
PMID: 24468059
Journal: Int J Oncol. 2014 Jun;44(6):2132-8.
Title: Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.
Author: Duong, Hong-Quan|Yi, Yong Weon|Kang, Hyo Jin|Bae, Insoo|Jang, Young-Joo|Kwak, Sahng-June|Seong, Yeon-Sun
PMID: 24676703
Journal: Pancreas. 2014 Jul;43(5):768-76.
Title: The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Author: Je, Dong Wook|O, Young Moon|Ji, Young Geon|Cho, Yunkyung|Lee, Dong Hyeon
PMID: 24763074
Journal: Cell Cycle. 2014;13(14):2172-91.
Title: Re-purposing clinical kinase inhibitors to enhance chemosensitivity by overriding checkpoints.
Author: Beeharry, Neil|Banina, Eugenia|Hittle, James|Skobeleva, Natalia|Khazak, Vladimir|Deacon, Sean|Andrake, Mark|Egleston, Brian L|Peterson, Jeffrey R|Astsaturov, Igor|Yen, Timothy J
PMID: 24955955
Journal: PLoS One. 2014 Aug 29;9(8):e105245.
Title: Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells.
Author: Gurbuz, Nilgun|Ashour, Ahmed A|Alpay, S Neslihan|Ozpolat, Bulent
PMID: 25170871
Journal: J Cell Mol Med. 2014 Nov;18(11):2235-51.
Title: Elongation factor-2 kinase regulates TG2/beta1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion.
Author: Ashour, Ahmed A|Gurbuz, Nilgun|Alpay, Sultan Neslihan|Abdel-Aziz, Abdel-Aziz H|Mansour, Ahmed M|Huo, Longfei|Ozpolat, Bulent
PMID: 25215932
Journal: PLoS One. 2014 Sep 30;9(9):e110067.
Title: Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells.
Author: Gurbuz, Nilgun|Ashour, Ahmed A|Alpay, S Neslihan|Ozpolat, Bulent
PMID: 25268648
Journal: Cell Adh Migr. 2014;8(5):478-86.
Title: Monitoring the dynamics of Src activity in response to anti-invasive dasatinib treatment at a subcellular level using dual intravital imaging.
Author: Nobis, Max|McGhee, Ewan J|Herrmann, David|Magenau, Astrid|Morton, Jennifer P|Anderson, Kurt I|Timpson, Paul
PMID: 25482620
Journal: Br J Pharmacol. 2015 Jan;172(1):50-63.
Title: Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells.
Author: Pathania, Divya|Kuang, Yuting|Sechi, Mario|Neamati, Nouri
PMID: 25047070
Journal: Mol Cancer Ther. 2015 Feb;14(2):407-18.
Title: A preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer.
Author: Pan, Youli|Zheng, Mingwu|Zhong, Lei|Yang, Jiao|Zhou, Shu|Qin, Ya|Xiang, Rong|Chen, Yuzong|Yang, Sheng-Yong
PMID: 25519702
Journal: Mol Pharmacol. 2015;87(3):543-60.
Title: Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (STAT3) pathway: inhibition of constitutive and interleukin 6-induced activation by iron depletion.
Author: Lui, Goldie Y L|Kovacevic, Zaklina|V Menezes, Sharleen|Kalinowski, Danuta S|Merlot, Angelica M|Sahni, Sumit|Richardson, Des R
PMID: 25561562
Journal: J Hepatobiliary Pancreat Sci. 2015 Aug;22(8):594-601.
Title: Molecular pathogenesis and targeted therapy of sporadic pancreatic neuroendocrine tumors.
Author: Capurso, Gabriele|Archibugi, Livia|Delle Fave, Gianfranco
PMID: 25619712
Journal: Sci Rep. 2015 Feb 13;5:8453.
Title: S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase.
Author: Che, Pulin|Yang, Youfeng|Han, Xiaosi|Hu, Meng|Sellers, Jeffery C|Londono-Joshi, Angelina I|Cai, Guo-Qiang|Buchsbaum, Donald J|Christein, John D|Tang, Qinjiu|Chen, Dongquan|Li, Qianjun|Grizzle, William E|Lu, Yin Ying|Ding, Qiang
PMID: 25677816
Journal: Oncoscience. 2015 Mar 14;2(3):285-93.
Title: N of 1 case reports of exceptional responders accrued from pancreatic cancer patients enrolled in first-in-man studies from 2002 through 2012.
Author: Garrido-Laguna, Ignacio|Tometich, Danielle|Hu, Nan|Ying, Jian|Geiersbach, Katherine|Whisenant, Jonathan|Wang, Kai|Ross, Jeffrey S|Sharma, Sunil
PMID: 25897431
Journal: Sci Rep. 2015 Jun 12;5:10867.
Title: Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer.
Author: Chatterjee, Moumita|Ben-Josef, Edgar|Thomas, Dafydd G|Morgan, Meredith A|Zalupski, Mark M|Khan, Gazala|Andrew Robinson, Charles|Griffith, Kent A|Chen, Ching-Shih|Ludwig, Thomas|Bekaii-Saab, Tanios|Chakravarti, Arnab|Williams, Terence M
PMID: 26065715
Journal: Oncotarget. 2015 Sep 22;6(28):25308-19.
Title: Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.
Author: Yuan, Kaiyu|Yong, Sun|Xu, Fei|Zhou, Tong|McDonald, Jay M|Chen, Yabing
PMID: 26320171
Journal: Oncotarget. 2015 Nov 24;6(37):39521-37.
Title: Novel agents for advanced pancreatic cancer.
Author: Akinleye, Akintunde|Iragavarapu, Chaitanya|Furqan, Muhammad|Cang, Shundong|Liu, Delong
PMID: 26369833
Journal: Int J Clin Exp Med. 2015 Nov 15;8(11):20349-54. eCollection 2015.
Title: Role of sphingosine 1-phosphate in human pancreatic cancer cells proliferation and migration.
Author: Guo, Yun-Xia|Ma, Ying-Jie|Han, Li|Wang, Yu-Jie|Han, Ji-Ao|Zhu, Ying
PMID: 26884951
Journal: Oncotarget. 2016 Feb 9;7(6):7253-67.
Title: A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer.
Author: Paladino, David|Yue, Peibin|Furuya, Hideki|Acoba, Jared|Rosser, Charles J|Turkson, James
PMID: 26695438
Journal: Bioorg Med Chem Lett. 2016 Feb 15;26(4):1237-44.
Title: Identification of initial leads directed at the calmodulin-binding region on the Src-SH2 domain that exhibit anti-proliferation activity against pancreatic cancer.
Author: Tzou, Ywh-Min|Bailey, Sarah K|Yuan, Kaiyu|Shin, Ronald|Zhang, Wei|Chen, Yabing|Singh, Raj K|Shevde, Lalita A|Krishna, N Rama
PMID: 26803204
Journal: Mol Med Rep. 2016 Jun;13(6):4774-8.
Title: Src/STAT3 signaling pathways are involved in KAI1-induced downregulation of VEGF-C expression in pancreatic cancer.
Author: Liu, Xu|Guo, Xiaozhong|Li, Hongyu|Chen, Jiang|Qi, Xingshun
PMID: 27082851
Journal: PLoS One. 2016 May 13;11(5):e0155264.
Title: Kaempferol Inhibits Pancreatic Cancer Cell Growth and Migration through the Blockade of EGFR-Related Pathway In Vitro.
Author: Lee, Jungwhoi|Kim, Jae Hoon
PMID: 27175782
Journal: Mol Cell Biol. 2016 Sep 26;36(20):2596-611.
Title: Unravelling the Mechanism of TrkA-Induced Cell Death by Macropinocytosis in Medulloblastoma Daoy Cells.
Author: Li, Chunhui|MacDonald, James I S|Talebian, Asghar|Leuenberger, Jennifer|Seah, Claudia|Pasternak, Stephen H|Michnick, Stephen W|Meakin, Susan O
PMID: 27503856
Journal: PLoS One. 2016 Oct 19;11(10):e0162821.
Title: Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells.
Author: Ma, Yong-Chao|Wang, Zhi-Xin|Jin, Shao-Ju|Zhang, Yan-Xin|Hu, Guo-Qiang|Cui, Dong-Tao|Wang, Jiang-Shuan|Wang, Min|Wang, Fu-Qing|Zhao, Zhi-Jun
PMID: 27760157
Journal: Cancer Res. 2017 Jan 1;77(1):41-52.
Title: Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer.
Author: Rucki, Agnieszka A|Foley, Kelly|Zhang, Pingbo|Xiao, Qian|Kleponis, Jennifer|Wu, Annie A|Sharma, Rajni|Mo, Guanglan|Liu, Angen|Van Eyk, Jennifer|Jaffee, Elizabeth M|Zheng, Lei
PMID: 27821486
Journal: Theranostics. 2017 Jan 11;7(3):594-613.
Title: Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity.
Author: Ahn, Hye-Mi|Ryu, Jihye|Song, Jin Myeong|Lee, Yunhee|Kim, Hye-Jin|Ko, Dongjoon|Choi, Inpyo|Kim, Sang Jick|Lee, Jung Weon|Kim, Semi
PMID: 28255353
Journal: Biochem Pharmacol. 2017 Sep 15;140:1-7.
Title: Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.
Author: Rohira, Aarti D|Lonard, David M
PMID: 28390937
Journal: Cell Rep. 2017 Jul 25;20(4):999-1015.
Title: A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution.
Author: Anderson, Grace R|Winter, Peter S|Lin, Kevin H|Nussbaum, Daniel P|Cakir, Merve|Stein, Elizabeth M|Soderquist, Ryan S|Crawford, Lorin|Leeds, Jim C|Newcomb, Rachel|Stepp, Priya|Yip, Catherine|Wardell, Suzanne E|Tingley, Jennifer P|Ali, Moiez|Xu, Mengmeng|Ry
PMID: 28746882
Journal: Invest New Drugs. 2018 Jun;36(3):442-450.
Title: Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trial.
Author: Cardin, Dana B|Goff, Laura W|Chan, Emily|Whisenant, Jennifer G|Dan Ayers, G|Takebe, Naoko|Arlinghaus, Lori R|Yankeelov, Thomas E|Berlin, Jordan|Merchant, Nipun
PMID: 28990119
Journal: Int J Mol Med. 2018 May;41(5):2813-2831.
Title: Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification.
Author: He, Rong-Quan|Wu, Pei-Rong|Xiang, Xue-Lian|Yang, Xia|Liang, Hai-Wei|Qiu, Xiao-Hui|Yang, Li-Hua|Peng, Zhi-Gang|Chen, Gang
PMID: 29484429
Journal: Am J Physiol Gastrointest Liver Physiol. 2018 Aug 1;315(2):G302-G317.
Title: P21-activated kinase 4 in pancreatic acinar cells is activated by numerous gastrointestinal hormones/neurotransmitters and growth factors by novel signaling, and its activation stimulates secretory/growth cascades.
Author: Ramos-Alvarez, Irene|Jensen, R T
PMID: 29672153
Journal: Cell Death Dis. 2018 May 1;9(5):538.
Title: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways.
Author: Li, Yang|Xi, Zhichao|Chen, Xiaoqiong|Cai, Shuangfan|Liang, Chen|Wang, Zhen|Li, Yingyi|Tan, Hongsheng|Lao, Yuanzhi|Xu, Hongxi
PMID: 29749405
Journal: Yonsei Med J. 2018 Aug;59(6):727-735.
Title: Synergistic Anti-Cancer Effects of AKT and SRC Inhibition in Human Pancreatic Cancer Cells.
Author: Ahn, Kang|O, Young Moon|Ji, Young Geon|Cho, Han Jun|Lee, Dong Hyeon
PMID: 29978609
Journal: Adv Biol Regul. 2018 Aug;69:16-34.
Title: Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals.
Author: Abrams, Stephen L|Lertpiriyapong, Kvin|Yang, Li V|Martelli, Alberto M|Cocco, Lucio|Ratti, Stefano|Falasca, Marco|Murata, Ramiro M|Rosalen, Pedro L|Lombardi, Paolo|Libra, Massimo|Candido, Saverio|Montalto, Giuseppe|Cervello, Melchiorre|Steelman, Linda S|Mc
PMID: 29980405
Journal: Clin Exp Metastasis. 2018 Jul 9. pii: 10.1007/s10585-018-9919-5.
Title: The therapeutic targeting of the FGFR1/Src/NF-kappaB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
Author: Lai, Shiue-Wei|Bamodu, Oluwaseun Adebayo|Tsai, Wen-Chiuan|Chang, Yi-Ming|Lee, Wei-Hwa|Yeh, Chi-Tai|Chao, Tsu-Yi
PMID: 29987671
Journal: Oncol Rep. 2018 Nov;40(5):3060-3068.
Title: Allergenremoved Rhus verniciflua Stokes suppresses invasion and migration of pancreatic cancer cells through downregulation of the JAK/STAT and Src/FAK signaling pathways.
Author: Kang, Youra|Yoon, Seong Woo|Park, Byoungduck
PMID: 30226611
Journal: Mol Oncol. 2018 Oct 20.
Title: Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207.
Author: You, Lei|Wang, Huanyu|Yang, Gang|Zhao, Fangyu|Zhang, Jingcheng|Liu, Ziwen|Zhang, Taiping|Liang, Zhiyong|Liu, Changzheng|Zhao, Yupei
PMID: 30341811